FDA & COVID-19: Discussion on Clinical Studies and Market Access in the United States

Überblick


Anisa Mohanty will be joining France Biotech to discuss legal and regulatory considerations when running clinical trials, managing supply chain risk, the FDA’s engagement strategies and more.

For additional information and to register, click here.